Anni Lotte Kirstine Sonderbjerg Pedersen, an officer of Ascendis Pharma A/S, filed a Form 144 notice on November 17, 2026, disclosing a proposed sale of 20,000 American Depositary Shares on NASDAQ.
Key Highlights
- Seller: Anni Lotte Kirstine Sonderbjerg Pedersen, identified as an officer of Ascendis Pharma A/S.
- Shares proposed for sale: 20,000 American Depositary Shares, with an aggregate market value of $5,277,721.70.
- Shares outstanding: 66,400,738 American Depositary Shares, according to the filing.
- Approximate date of sale: November 17, 2026, through broker Merrill Lynch, 225 Liberty Street, Floor 37, New York, NY 10281.
- Original acquisition: The 20,000 shares were acquired on December 12, 2017, via a warrant exercise from Ascendis Pharma A/S, with payment made in cash on the same date.
- Prior sales: The filing reports nothing to report for securities sold during the past three months.
Pedersen's Proposed ADS Sale: Acquisition History and Filing Details
According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Anni Lotte Kirstine Sonderbjerg Pedersen, an officer of Ascendis Pharma A/S (NASDAQ:ASND), proposes to sell 20,000 American Depositary Shares. The filing lists an aggregate market value of $5,277,721.70 for the proposed transaction, with the approximate date of sale noted as November 17, 2026. The designated broker is Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, NY 10281.
The filing discloses that the 20,000 shares proposed for sale were originally acquired on December 12, 2017, through a warrant exercise from Ascendis Pharma A/S. The nature of payment is listed as cash, also dated December 12, 2017. The filing reports that no securities of the issuer were sold by the filer during the past three months. The total number of American Depositary Shares outstanding is listed as 66,400,738.
By signing the notice, the filing states, the seller "represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." No written trading plan or Rule 10b5-1 instruction date is noted in the filing.
What Was Disclosed
Ascendis Pharma A/S officer Anni Lotte Kirstine Sonderbjerg Pedersen filed a Form 144 notice proposing the sale of 20,000 American Depositary Shares, acquired via warrant exercise in December 2017, with an aggregate market value of $5,277,721.70.




Please wait processing your request...